跳至主要内容
临床试验/NCT03293134
NCT03293134已完成不适用

Clinical and Molecular Characterization of Cerebral Proliferative Vasculopathy

Assistance Publique - Hôpitaux de Paris1 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2013年7月8日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
25
试验地点
1
主要终点
Morphological analysis

研究概览

简要总结

As principal objective, the study aims to:

  1. Describe the spectrum and evaluate the frequency of angiodysplasia of the nevrax;
  2. Establish the physiopathological basis of Fowler's syndrome;
  3. Identify FLVCR2 partners and the signaling pathways involved;
  4. Test new candidate genes: GPR124 and possible partners of FLVCR2.

As second objective, the study aims to:

  • perform phenotype / genotype correlation if necessary;
  • and propose a prenatal diagnosis in families with identified mutations.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Other

入排标准

性别
All
接受健康志愿者

入选标准

  • Angiodysplasia restricted to central nervous system with or without glomerular vasculopathy.
  • Informed consent signed.

排除标准

  • Vascular malformations not confined to the nevrax.
  • No signature of consent.

结局指标

主要结局

Morphological analysis

时间窗: throughout the study: 36 months

Morphological analysis : characterisation of cellular lesions by immunolabelling with endothelial markers such as CD34 and CD31, pericytic markers (smooth muscle actin and proteoglycan NG2) and astrocytic markers (GFAP)

次要结局

  • Identification of novel disease(throughout the study: 36 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Clinical and Molecular Characterization of Cerebral... | 临床试验